drug · antibody
patient view →siplizumab
Phase 2updated 2mo agoby ITB-Med AB🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 11 investigational indications.
targets
T-cell surface antigen CD2
all catalysts(1)
phase 2 initiation · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that